Orgenesis Inc. (ORGS)
Develops cell and gene therapies using automated point-of-care technology in hospitals.
$0.40+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+1718.2%
The outlook
ORGS trades at $0.40, sitting above both its 50- and 200-day moving averages in the lower half of its 52-week range. Analyst coverage appears thin on publicly available data. The StockGlow score leans bullish at 67/100, reflecting a moderately positive sentiment backdrop.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range40% of the way from its 52-week low to high
Market cap
$3.9M
52-wk high
$1.00
52-wk low
$0.00
50-day avg
$0.37
200-day avg
$0.38
Trailing P/E
—